DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Micardis (Telmisartan) - Adverse Event Reports - Death - Duodenal Ulcer

 



Index of reports > Cases resulting in death (59) > Cases with Duodenal Ulcer (8)

Below is the selection of adverse event reports related to Micardis (Telmisartan) that includes cases resulting in death where reactions include duodenal ulcer.

Adverse event in female receiving Micardis (Telmisartan)

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-06-06

Patient: female

Adverse reactions / side effects: Sepsis, Duodenal Ulcer, Renal Failure Chronic, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Dosage: 200mg/25mg bid
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-16

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-12

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-16



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Malaysia on 2007-06-01

Patient: female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Sepsis, Duodenal Ulcer, Renal Failure Chronic, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-12

Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-16

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-16

Other drugs received by patient: Cloxacillia; Tazocin; Fortum



Adverse event in female receiving Micardis (Telmisartan)

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-05-15

Patient: female

Adverse reactions / side effects: Duodenal Ulcer, Renal Failure Chronic, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Dosage: 200mg/25mg bid
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-16

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-16

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident
    Start date: 2004-12-28
    End date: 2007-03-12



Adverse event in female receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from Malaysia on 2007-05-11

Patient: female, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Duodenal Ulcer, Renal Failure Chronic, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-12

Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-16

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2004-12-28
    End date: 2007-03-16



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from India on 2007-03-23

Patient: male, weighing 45.0 kg (99.0 pounds)

Adverse reactions / side effects: Duodenal Ulcer Perforation, Cardio-Respiratory Arrest, Peptic Ulcer, Sepsis, Duodenal Ulcer, Acute Respiratory Failure

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from India on 2007-02-02

Patient: male, weighing 45.0 kg (99.0 pounds)

Adverse reactions / side effects: Duodenal Ulcer Perforation, Cardio-Respiratory Arrest, Peptic Ulcer, Sepsis, Duodenal Ulcer, Acute Respiratory Failure

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from India on 2007-01-22

Patient: male, weighing 45.0 kg (99.0 pounds)

Adverse reactions / side effects: Duodenal Ulcer Perforation, Cardio-Respiratory Arrest, Peptic Ulcer, Sepsis, Duodenal Ulcer, Acute Respiratory Failure

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14



Adverse event in male receiving Micardis (Telmisartan)

Reported by a individual with unspecified qualification from India on 2007-01-15

Patient: male, weighing 45.0 kg (99.0 pounds)

Adverse reactions / side effects: Duodenal Ulcer Perforation, Cardio-Respiratory Arrest, Peptic Ulcer, Sepsis, Duodenal Ulcer, Acute Respiratory Failure

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Aggrenox
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Micardis
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

Clopidogrel
    Administration route: Oral
    Indication: Cerebrovascular Accident Prophylaxis
    Start date: 2005-12-01
    End date: 2006-07-14

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009